Extraarticular manifestations of rheumatoid arthritis develop in patients receiving anti-tumor necrosis factor-α treatment: a retrospective chart review from a UK center
- PMID: 25179847
- DOI: 10.3899/jrheum.131026
Extraarticular manifestations of rheumatoid arthritis develop in patients receiving anti-tumor necrosis factor-α treatment: a retrospective chart review from a UK center
Abstract
Objective: To assess the evolution of preexisting extraarticular manifestations of rheumatoid arthritis (EA-RA) in patients treated with anti-tumor necrosis factor-α (TNF-α), as well as the development of new EA-RA.
Methods: We assessed EA-RA in 152 patients receiving anti-TNF-α treatment.
Results: In 22 cases, a new EA-RA developed. In 5 cases, there was evidence of progression of preexisting EA-RA. Regression was found in 4 cases. Some patients were in disease remission when they developed EA-RA, whereas some patients had moderate/high disease activity.
Conclusion: EA-RA are still present in patients treated with anti-TNF-α. Development of new severe EA-RA is rare in patients receiving anti-TNF therapy.
Keywords: EXTRAARTICULAR MANIFESTATIONS; RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR-α.
Comment in
-
Extraarticular Manifestations of Rheumatoid Arthritis in Patients under Anti-tumor Necrosis Factor-α Treatment.J Rheumatol. 2015 Jun;42(6):1059. doi: 10.3899/jrheum.141273. J Rheumatol. 2015. PMID: 26034229 No abstract available.
-
Drs. Negoescu and Abraham reply.J Rheumatol. 2015 Jun;42(6):1060. doi: 10.3899/jrheum.150229. J Rheumatol. 2015. PMID: 26034231 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical